Premium
Healthtech platform Redcliffe Labs, which recently secured $42 million (Rs 335 crore) in Series C funding, has pushed the timeline for a public listing as it has decided to prioritise profitability that may delay their targeted revenue for an IPO. The diagnostics service provider originally targeted a public offering in the financial year ending ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
